PL
GILD icon

Polianta Ltd’s Gilead Sciences GILD Stock Holding History

Polianta Ltd’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-17,000
Closed -$1.15M – 81
2019
Q2 		$1.15M Sell
17,000
-500
-3% -$32.9K 0.5% 36
2019
Q1 		$1.14M Buy
17,500
+700
+4% +$46.5K 0.43% 55
2018
Q4 		$1.05M Buy
16,800
+800
+5% +$55.9K 0.52% 56
2018
Q3 		$1.24M Sell
16,000
-900
-5% -$68K 0.62% 33
2018
Q2 		$1.2M Buy
16,900
+1,600
+10% +$113K 0.37% 35
2018
Q1 		$1.15M Sell
15,300
-2,100
-12% -$167K 0.35% 54
2017
Q4 		$1.25M Hold
17,400
– – 0.4% 46
2017
Q3 		$1.41M Hold
17,400
– – 0.45% 26
2017
Q2 		$1.23M Buy
17,400
+3,300
+23% +$220K 0.52% 25
2017
Q1 		$957K Hold
14,100
– – 0.57% 65
2016
Q4 		$1.01M Buy
+14,100
New +$1.05M 0.55% 63

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Polianta Ltd's GILD Position: Q3 2019 in Review

Polianta Ltd sold out of Gilead Sciences (GILD) in Q3 2019, closing a stake of 17,000 shares — an estimated $1.15M sold.

Polianta Ltd first reported a position in GILD in Q4 2016 and held it in 11 quarters. The position peaked at $1.41M in Q3 2017. 1,462 funds tracked by Wall St. Rank hold GILD as of Q3 2019.

  • Polianta Ltd reported no remaining Gilead Sciences position as of Q3 2019 after selling out during the quarter.
  • Polianta Ltd sold 17,000 Gilead Sciences shares in Q3 2019, an estimated $1.15M.
  • Polianta Ltd first reported a position in Gilead Sciences in Q4 2016 and held it in 11 quarters.
  • Polianta Ltd's Gilead Sciences position peaked at $1.41M in Q3 2017.
  • 1,462 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2019.

Based on Polianta Ltd's 13F filing for Q3 2019, filed 9 Oct 2019.